PRESS RELEASE published on 09/29/2025 at 23:00, 5 months 23 days ago Inside Information / News release on accounts, results GenSight Biologics reports 8.3% reduction in operating cash outflow and extends cash runway to late Q4 2025. Company's financial results show decrease in operating income, R&D expenses, and net cash flows Financial Results Operating Income Cash Management GenSight Biologics R&D Expenses
PRESS RELEASE published on 09/29/2025 at 23:00, 5 months 23 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie résultats financiers du premier semestre 2025 : gestion optimisée de trésorerie, financement post-clôture, transfert de fabrication, protocole d'étude soumis à l'ANSM Résultats Financiers Financement Trésorerie GenSight Biologics Étude ANSM
PRESS RELEASE published on 09/29/2025 at 21:48, 5 months 23 days ago rapport financier semestriel 2025
BRIEF published on 08/28/2025 at 20:05, 6 months 25 days ago GenSight Biologics reporte la publication de ses résultats financiers semestriels 2025 Résultats Financiers Conformité Réglementaire Report GenSight Biologics Procédures D'audit
BRIEF published on 08/28/2025 at 20:05, 6 months 25 days ago GenSight Biologics Delays 2025 Half-Year Financial Results Announcement Financial Results Regulatory Compliance Postponement GenSight Biologics Audit Procedures
PRESS RELEASE published on 08/28/2025 at 20:00, 6 months 25 days ago Inside Information / Other news releases GenSight Biologics postpones the release of its 2025 half-year financial results to September 29, 2025, after the market closes, to ensure highest audit standards. No material issues reported. Audit Committee and Board meetings rescheduled Financial Results Transparency Postponement GenSight Biologics Audit Procedures
PRESS RELEASE published on 08/28/2025 at 20:00, 6 months 25 days ago Informations privilégiées / Autres communiqués GenSight Biologics reporte la publication de ses résultats financiers semestriels 2025. Le report est dû à l'audit en cours, non lié à des problèmes financiers. Réunions importantes reprogrammées Résultats Financiers Communication Financière Audit Report GenSight Biologics
BRIEF published on 07/17/2025 at 15:05, 8 months 6 days ago GenSight Biologics: Publication of an article on the predictions of LUMEVOQ® gene therapy Gene Therapy GenSight Biologics NOHL LUMEVOQ Visual Acuity
BRIEF published on 07/17/2025 at 15:05, 8 months 6 days ago GenSight Biologics : publication d'un article sur les prédictions de la thérapie génique LUMEVOQ® Thérapie Génique GenSight Biologics NOHL LUMEVOQ Acuité Visuelle
PRESS RELEASE published on 07/17/2025 at 15:00, 8 months 6 days ago Informations privilégiées / Autres communiqués GenSight Biologics annonce la publication d'un article sur les facteurs prédictifs du résultat visuel final chez les patients traités par la thérapie génique LUMEVOQ® Thérapie Génique GenSight Biologics LUMEVOQ Facteurs Prédictifs Résultat Visuel Final
Published on 03/23/2026 at 14:05, 5 hours 5 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 5 hours 10 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 6 hours 5 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 6 hours 38 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 6 hours 40 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 18:15, 54 minutes ago ISX Financial EU Plc Announces Corporate Name Change to Xryma Plc
Published on 03/23/2026 at 17:54, 1 hour 15 minutes ago EQS-Adhoc: net digital AG publishes 2026 forecast with continued growth in revenue and earnings
Published on 03/23/2026 at 17:45, 1 hour 24 minutes ago Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile.
Published on 03/23/2026 at 18:37, 32 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 1 hour 24 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 1 hour 24 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
Published on 03/23/2026 at 17:45, 1 hour 25 minutes ago Share buyback for allocation to employees or corporate officers
